Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia.
Fiche du document
2009
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00417-009-1117-3
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/19727795
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1435-702X[electronic]
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_E7DF530977860
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Mots-clés
Macular Telangiectasia; Bevacizumab Avastin; Subretinal Neovascularization; Photodynamic TherapySujets proches
TelangiectasisCiter ce document
L. Konstantinidis et al., « Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia. », Serveur académique Lausannois, ID : 10.1007/s00417-009-1117-3
